Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: Physician practice in the CRUSADE registry-Reference-Cited by-同舟云学术

Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: Physician practice in the CRUSADE registry

Published:2008-02 Issue:2 Volume:155 Page:361-368
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Wang Tracy Y.,Robinson Lee A.,Ou Fang-Shu,Roe Matthew T.,Ohman E. Magnus,Gibler W. Brian,Smith Sidney C.,Peterson Eric D.,Becker Richard C.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy;Hirsh;J Am Coll Cardiol,2003

2. Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis;Choudhry;BMJ,2006

3. Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics;Choudhry;Am J Med,2006

4. Anticoagulant-related bleeding in older persons with atrial fibrillation: physicians' fears often unfounded;Man-Son-Hing;Arch Intern Med,2003

5. Antithrombotic treatment after coronary artery stenting in patients on chronic oral anticoagulation: an international survey of current clinical practice;Rubboli;Ital Heart J,2004

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal Antithrombotic Therapy Beyond 1-Year After Coronary Revascularization in Patients With Atrial Fibrillation;Journal of Korean Medical Science;2024

2. Dual compared with triple antithrombotics treatment effect on ischemia and bleeding in atrial fibrillation following percutaneous coronary intervention: A meta-analysis;International Journal of Clinical Medical Research;2023-09-28

3. Triple Antiplatelet Therapy and Combinations with Oral Anticoagulants after Percutaneous Coronary Intervention;Interventional Cardiology;2022-05-06

4. Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial;EuroIntervention;2021-08

5. Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence;EUR J INTERN MED;2020